Iovance Biotherapeutics
Iovance Biotherapeutics, founded in 2007 and headquartered in San Carlos, California, is a biopharmaceutical company developing tumor-infiltrating lymphocyte therapies against cancer.
Last updated on
About Iovance Biotherapeutics
Founded
2007Estimated Revenue
$100M-$250MEmployees
251-1KFunding / Mkt. Cap
$712MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
541711Location
City
San CarlosState
CaliforniaCountry
United StatesTech Stack (95)
.png)
